![](https://www.mitacs.ca/wp-content/uploads/2023/12/generic-logo-background.png)
The intern will use screening methods to define which gene which are altered in the Jurkat human T cell line following incubation with the Verotoxin B subunit as a means to define the potential mechanism by which this treatment protects these cells from HIV1 infection in vitro. LISI Therapeutics will benefit by increasing their license […]
Read More